Lv11
26 积分 2022-04-06 加入
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
5小时前
已完结
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial
7天前
已完结
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial
7天前
已完结
中国放射性直肠炎诊治专家共识（2018版）
16天前
已完结
NSCLC: Five trials to watch
1个月前
已完结
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
1个月前
已完结
益口与康复新液联用防治白血病患者化疗性口腔黏膜炎的护理
1个月前
已完结
Contemporary Computational Applications and Tools in Drug Discovery
2个月前
已完结
放射性口腔黏膜炎辐射防护专家共识
2个月前
已完结
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
